Style | Citing Format |
---|---|
MLA | Khandan M, et al.. "Synthesis and Cytotoxic Evaluation of Some Novel Diarylamide Possessing Quinoxalinedione Based on Sorafenib." Research in Pharmaceutical Sciences, vol. 13, no. 2, 2018, pp. 168-176. |
APA | Khandan M, Rizi S, Khodarahmi G, Hassanzadeh F (2018). Synthesis and Cytotoxic Evaluation of Some Novel Diarylamide Possessing Quinoxalinedione Based on Sorafenib. Research in Pharmaceutical Sciences, 13(2), 168-176. |
Chicago | Khandan M, Rizi S, Khodarahmi G, Hassanzadeh F. "Synthesis and Cytotoxic Evaluation of Some Novel Diarylamide Possessing Quinoxalinedione Based on Sorafenib." Research in Pharmaceutical Sciences 13, no. 2 (2018): 168-176. |
Harvard | Khandan M et al. (2018) 'Synthesis and Cytotoxic Evaluation of Some Novel Diarylamide Possessing Quinoxalinedione Based on Sorafenib', Research in Pharmaceutical Sciences, 13(2), pp. 168-176. |
Vancouver | Khandan M, Rizi S, Khodarahmi G, Hassanzadeh F. Synthesis and Cytotoxic Evaluation of Some Novel Diarylamide Possessing Quinoxalinedione Based on Sorafenib. Research in Pharmaceutical Sciences. 2018;13(2):168-176. |
BibTex | @article{ author = {Khandan M and Rizi S and Khodarahmi G and Hassanzadeh F}, title = {Synthesis and Cytotoxic Evaluation of Some Novel Diarylamide Possessing Quinoxalinedione Based on Sorafenib}, journal = {Research in Pharmaceutical Sciences}, volume = {13}, number = {2}, pages = {168-176}, year = {2018} } |
RIS | TY - JOUR AU - Khandan M AU - Rizi S AU - Khodarahmi G AU - Hassanzadeh F TI - Synthesis and Cytotoxic Evaluation of Some Novel Diarylamide Possessing Quinoxalinedione Based on Sorafenib JO - Research in Pharmaceutical Sciences VL - 13 IS - 2 SP - 168 EP - 176 PY - 2018 ER - |